Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
06 06 2023
Historique:
received: 05 01 2023
accepted: 26 05 2023
revised: 19 05 2023
medline: 8 6 2023
pubmed: 7 6 2023
entrez: 6 6 2023
Statut: epublish

Résumé

People living with HIV are at increased risk for depression, though the underlying mechanisms for this are unclear. In the general population, depression is associated with peripheral and central inflammation. Given this, and since HIV infection elicits inflammation, we hypothesised that peripheral and central inflammatory biomarkers would at least partly mediate the association between HIV and depressive symptoms. People living with HIV (n = 125) and without HIV (n = 79) from the COmorBidity in Relation to AIDS (COBRA) cohort were included in this study. Participants living with and without HIV had similar baseline characteristics. All participants living with HIV were on antiretroviral therapy and were virally suppressed. Plasma, CSF, and brain MR spectroscopy (MRS) biomarkers were measured. Using logistic regression models adjusted for sociodemographic factors, we found that participants with HIV were more likely to have Any Depressive Symptoms (Patient Health Questionnaire [PHQ-9] score >4) (odds ratio [95% confidence interval] 3.27 [1.46, 8.09]). We then sequentially adjusted the models for each biomarker separately to determine the mediating role of each biomarker, with a >10% reduction in OR considered as evidence of potential mediation. Of the biomarkers analysed, MIG (-15.0%) and TNF-α (-11.4%) in plasma and MIP1-α (-21.0%) and IL-6 (-18.0%) in CSF mediated the association between HIV and depressive symptoms in this sample. None of the other soluble or neuroimaging biomarkers substantially mediated this association. Our findings suggest that certain biomarkers of central and peripheral inflammation may at least partly mediate the relationship between HIV and depressive symptoms.

Identifiants

pubmed: 37280232
doi: 10.1038/s41398-023-02489-0
pii: 10.1038/s41398-023-02489-0
pmc: PMC10244452
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

190

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

AIDS. 2015 Jan 2;29(1):43-51
pubmed: 25387317
J Neurovirol. 2022 Feb;28(1):54-63
pubmed: 34874540
BMC Immunol. 2018 Jan 03;19(1):1
pubmed: 29298663
Am J Psychiatry. 2001 May;158(5):725-30
pubmed: 11329393
BMJ Support Palliat Care. 2019 Dec;9(4):404-412
pubmed: 31537580
PLoS One. 2018 Mar 29;13(3):e0191791
pubmed: 29596425
Brain Behav Immun. 2019 Jan;75:200-207
pubmed: 30394311
Brain Behav Immun. 2020 Nov;90:353-363
pubmed: 32966871
Nat Rev Immunol. 2016 Jan;16(1):22-34
pubmed: 26711676
BMC Med. 2012 Jun 29;10:66
pubmed: 22747645
Mol Psychiatry. 2019 Jun;24(6):888-900
pubmed: 30824865
Exp Gerontol. 2018 Feb;102:109-132
pubmed: 29237576
AIDS. 2017 Jun 19;31(10):1471-1481
pubmed: 28574965
J Neurochem. 2010 Jul;114(1):97-109
pubmed: 20403075
EBioMedicine. 2015 Nov 22;3:135-140
pubmed: 26870824
JAMA Psychiatry. 2014 Dec 1;71(12):1381-91
pubmed: 25322082
Brain Pathol. 2014 Nov;24(6):654-64
pubmed: 25345895
BMJ. 2019 Apr 9;365:l1476
pubmed: 30967483
Mol Psychiatry. 2018 Jan;23(1):48-58
pubmed: 29133955
Mol Psychiatry. 2022 Sep;27(9):3619-3632
pubmed: 35618889
AIDS Res Ther. 2021 Apr 27;18(1):23
pubmed: 33906698
Eur J Radiol. 2008 Aug;67(2):250-257
pubmed: 18407447
Pediatr Infect Dis J. 2007 Oct;26(10):935-44
pubmed: 17901800
J Affect Disord. 2013 Sep 25;150(3):736-44
pubmed: 23870425
J Neuroimmune Pharmacol. 2013 Jun;8(3):576-93
pubmed: 23666436
Psychoneuroendocrinology. 2020 Apr;114:104609
pubmed: 32062371
PLoS One. 2021 May 13;16(5):e0250987
pubmed: 33983973
Biol Psychiatry. 2009 May 1;65(9):732-41
pubmed: 19150053
J Int AIDS Soc. 2021 Jun;24 Suppl 2:e25748
pubmed: 34164925
J Neurovirol. 2014 Feb;20(1):28-38
pubmed: 24420447
Brain Behav Immun. 2022 Jan;99:256-265
pubmed: 34673176
J Neurovirol. 2021 Feb;27(1):70-79
pubmed: 33145707
Eur J Neurosci. 2021 Jan;53(1):151-171
pubmed: 32150310
Clin Infect Dis. 2018 Jun 1;66(12):1899-1909
pubmed: 29309532
HIV Med. 2019 Feb;20(2):131-136
pubmed: 30548745
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Curr HIV/AIDS Rep. 2008 Nov;5(4):163-71
pubmed: 18838056
Front Immunol. 2019 Aug 27;10:1965
pubmed: 31507593

Auteurs

Arish Mudra Rakshasa-Loots (A)

Edinburgh Neuroscience, School of Biomedical Sciences, The University of Edinburgh, Edinburgh, UK. Arish.MudraRakshasa@ed.ac.uk.
Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK. Arish.MudraRakshasa@ed.ac.uk.

Nicholas Bakewell (N)

Institute for Global Health, University College London, London, UK.

David J Sharp (DJ)

Department of Brain Sciences, Imperial College London, London, UK.
Care Research & Technology Centre, UK Dementia Research Institute, London, UK.

Magnus Gisslén (M)

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Department of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.

Henrik Zetterberg (H)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
UK Dementia Research Institute at UCL, London, UK.
Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.
Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

Jasmini Alagaratnam (J)

Department of Infectious Disease, Imperial College London, London, UK.
Department of Sexual Health and HIV, Chelsea & Westminster Hospital NHS Foundation Trust, London, UK.

Ferdinand W N M Wit (FWNM)

Stichting HIV Monitoring, Amsterdam, The Netherlands.
Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
Amsterdam UMC location University of Amsterdam, Global Health, Amsterdam, The Netherlands.
Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.

Neeltje A Kootstra (NA)

Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Alan Winston (A)

Department of Infectious Disease, Imperial College London, London, UK.

Peter Reiss (P)

Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.
Amsterdam UMC location University of Amsterdam, Global Health, Amsterdam, The Netherlands.
Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.

Caroline A Sabin (CA)

Institute for Global Health, University College London, London, UK.

Jaime H Vera (JH)

Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH